A case of recurrent gastric cancer successfully treated with TS-1

T. Onoda, S. Okamura, N. Takakura, S. Shiozaki, S. Ohno, K. Higaki, M. Ninomiya, T. Ikeda, N. Kobayashi

研究成果: Contribution to journalArticle査読

1 被引用数 (Scopus)


A patient with recurrent gastric cancer which infiltrated the pelvic muscle after the treatment of paraaortic lymph node and ovarian metastases was successfully managed by a novel oral anticancer drug, TS-1. TS-1 was administered at a dose of 80 mg/day. One course consisted of two repetitions of consecutive administration of TS-1 for 14 days and withdrawal of TS-1 for 14 days. Adverse reactions were mild and the patient did not request hospitalization after two courses had been completed. Subjective symptoms such as difficulty in walking improved after one week and a partial response was obtained after 2 weeks of treatment. At the end of 4 courses we could remove an indwelling pyelocatheter for the ureter stricture. As of 14 months after the beginning of administration of TS-1, the patient is being treated as an outpatient and has attained a better QOL than before.

ジャーナルGan to kagaku ryoho. Cancer & chemotherapy
出版ステータス出版済み - 4 2001

All Science Journal Classification (ASJC) codes

  • 腫瘍学
  • 癌研究


「A case of recurrent gastric cancer successfully treated with TS-1」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。